This latest grant is part of a larger $500 million CMS program designed to identify and support communities in need.
healthcare navigator © talaj - stock.adobe.com
CMS awarded $100 million in grants to 44 organizations dedicated to enrolling people in underserved and vulnerable communities in Affordable Care Act Marketplace health plans, according to a Monday news release published on its website. In 2024, these organizations, called Navigators, helped contribute to a historic 21.4 million Marketplace enrollments, up more than 77% from 2021. To encourage smaller-community based organizations to apply to become Navigators, CMS streamlined the application process this year.
These grants are part of a $500 million commitment to be released over five years, the longest grant period and biggest financial commitment to the Navigator program to date.
At-risk populations are identified by common social determinants of health such as geographic location, sexual identity and gender. Members of these communities are often at a higher risk of housing inequality, food instability and lack of employment. Recent data from the U.S. Department of Health and Human Services shows that by focusing on these communities, insurance rates are up.
Using census data from 2010 to 2022, uninsurance rates have dropped in the following communities:
Navigators are vetted and trained by the CMS and their assistance is free to enrollees, whether someone is just exploring Marketplace options or is looking to sign up for a plan. They focus on individuals as well as small businesses. With Navigator’s help, four in five HealthCare.gov customers have been able to choose from coverage options that were $10 or less per month after subsidies.
Navigators can also assist people in helping enroll in or renew Medicaid and Children’s Health Insurance Program (CHIP) coverage
Examples of current Navigators include:
“Having access to trusted local partners is key to improving access to health services, particularly for those who just need a little extra help to understand the critical lifeline available through the ACA Marketplace and how to choose the best plan to meet their needs,” CMS Administrator Chiquita Brooks-LaSure said in the news release.
CMS has provided funding for Navigators since 2013.
Marketplace Open Enrollment begins on Nov. 1, 2024, and will last until at least Jan. 15, 2025, in some states. Enrollees interested in support can find assistance at Find Local Help. A full list of current Navigators is available here.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More
2 Commerce Drive
Cranbury, NJ 08512